Biosite Inc. Recalls Cardiac Marker Test

Law360, New York (May 6, 2009, 12:00 AM EDT) -- Research-based diagnostics company Biosite Inc. has issued a nationwide recall of one lot of its Triage Cardiac Panel, a product used to diagnose heart attacks, because of a defect that could possibly lead to a wrong diagnosis.

On Tuesday, the company voluntarily recalled 401 of its Triage Cardiac Panel kits because of “reports of low recovery of quality control samples containing Creatine Kinase MB (CK-MB), troponin I and myoglobin on the affected lot."

“Although there have been no reported issues of patient misdiagnosis associated with this...
To view the full article, register now.